Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Rosopatamab tetraxetan (ADC) (DHG01399)

Applications:Research Grade Biosimilar
Overview

Catalog No.

DHG01399

Description

Rosopatamab tetraxetan is an ADC consisting of a PSMA-directed antibody and DM1, a potent derivative of maytansine, used for the study of prostate cancer.

Species reactivity

Human

Clonality

Monoclonal

Target

PSMA

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SEC.

Purification

Purified by Ion Exchange Chromatography.

Applications

Research Grade Biosimilar

Form

Liquid

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Rosopatamab tetraxetan

Data Image
References
Datasheet

Document Download

Rosopatamab tetraxetan (ADC).pdf

 

$ 2540
Product specifications
1 mg 2540 5 mg 6360

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Rosopatamab tetraxetan (ADC) [DHG01399]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only